Atlas Trials

Assess the Feasibility and Safety of Granulocyte Colony Stimulating Factor (GCSF) Mobilization of CD34+ Hematopoietic Progenitor Cells in Patients With Betathalassemia Major

Clinical trial NCT00658385 · COMPLETED

Trial details

NCT number
NCT00658385
Sponsor
Memorial Sloan Kettering Cancer Center
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Beta Thalassemia MajorCongenital Anemias
Start date
2008-04-01
Primary completion
2011-02-01
Enrollment
5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.